Literature DB >> 21613804

Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.

Akinori Funayama1, Jun Cheng, Satoshi Maruyama, Manabu Yamazaki, Takanori Kobayashi, Mei Syafriadi, Sukalyan Kundu, Susumu Shingaki, Chikara Saito, Takashi Saku.   

Abstract

OBJECTIVE: Podoplanin, a known lymphatic endothelial cell marker, has been reported to be expressed in various types of cancer. To elucidate the expression of podoplanin in precancerous lesions, we examined the immunohistochemical profiles of podoplanin in oral squamous epithelial lesions.
METHOD: We studied a total of 298 foci of squamous cell carcinoma (SCC), carcinoma in situ (CIS), epithelial dysplasia, and hyperplastic and/or normal epithelial lesions by immunohistochemistry using D2-40.
RESULTS: There was no positivity for podoplanin in normal or hyperplastic epithelia, while all of the CIS and SCC foci stained positive. Approximately one third of the mild dysplasia foci (10 of 36 foci, 28%) and 80% of moderate dysplasia foci (78/98) showed grade 1 positive reactions (positive only in the 1st layer). Grade 2 reactions (up to 4th layer) were seen in 4 of 98 moderate dysplasia foci (4%), 29 of 74 CIS foci (39%), and 3 of 30 SCC foci (10%). Grade 3 reactions (to more than 5th layer) were found in 35 (47%) CIS foci and 26 (87%) SCC foci.
CONCLUSIONS: The relationship between the present histological categorization and podoplanin grade was statistically significant. D2-40 expression is considered to be related to the severity of oral precancerous lesions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613804     DOI: 10.1159/000324926

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  22 in total

1.  Intraepithelially entrapped blood vessels in oral carcinoma in-situ.

Authors:  Akinori Funayama; Satoshi Maruyama; Manabu Yamazaki; Kamal Al-Eryani; Susumu Shingaki; Chikara Saito; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2012-04-05       Impact factor: 4.064

2.  Expression of podoplanin in the invasion front of oral squamous cell carcinoma is not prognostic for survival.

Authors:  Juan Carlos de Vicente; Tania Rodríguez Santamarta; Juan Pablo Rodrigo; Juana María García-Pedrero; Eva Allonca; Verónica Blanco-Lorenzo
Journal:  Virchows Arch       Date:  2015-03-01       Impact factor: 4.064

3.  High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma.

Authors:  Miia Seppälä; Konsta Pohjola; Jussi Laranne; Markus Rautiainen; Heini Huhtala; Risto Renkonen; Karl Lemström; Timo Paavonen; Sanna Toppila-Salmi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

4.  Low-risk population among patients with tumor-node-metastasis stage III/IV oral squamous cell carcinoma.

Authors:  Tohru Ikeda; Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Yuu Ozaki-Honda; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina
Journal:  Oncol Lett       Date:  2017-07-15       Impact factor: 2.967

5.  Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.

Authors:  Harumi Inoue; Yuji Miyazaki; Kentaro Kikuchi; Noriaki Yoshida; Fumio Ide; Yoshihiro Ohmori; Akihito Tomomura; Hideaki Sakashita; Kaoru Kusama
Journal:  Tumour Biol       Date:  2011-11-12

6.  Keratin 17 is co-expressed with 14-3-3 sigma in oral carcinoma in situ and squamous cell carcinoma and modulates cell proliferation and size but not cell migration.

Authors:  Toshihiko Mikami; Satoshi Maruyama; Tatsuya Abé; Takanori Kobayashi; Manabu Yamazaki; Akinori Funayama; Susumu Shingaki; Tadaharu Kobayashi; Cheng Jun; Takashi Saku
Journal:  Virchows Arch       Date:  2015-03-04       Impact factor: 4.064

7.  Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification.

Authors:  Sachiko Seki; Mutsunori Fujiwara; Masaaki Matsuura; Shuichi Fujita; Hisazumi Ikeda; Masahiro Umeda; Izumi Asahina; Tohru Ikeda
Journal:  Pathol Oncol Res       Date:  2013-11-28       Impact factor: 3.201

8.  Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.

Authors:  Harini Krishnan; Jhon A Ochoa-Alvarez; Yongquan Shen; Evan Nevel; Meenakshi Lakshminarayanan; Mary C Williams; Maria I Ramirez; W Todd Miller; Gary S Goldberg
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

9.  Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.

Authors:  Agnes Assao; Suely Nonogaki; José Roberto Pereira Lauris; André Lopes Carvalho; Clóvis Antônio Lopes Pinto; Fernando Augusto Soares; Luiz Paulo Kowalski; Denise Tostes Oliveira
Journal:  Clin Oral Investig       Date:  2016-09-14       Impact factor: 3.573

Review 10.  Podoplanin--a novel marker in oral carcinogenesis.

Authors:  Niharika Swain; Shwetha V Kumar; Samapika Routray; Jigna Pathak; Shilpa Patel
Journal:  Tumour Biol       Date:  2014-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.